Matrix metalloproteinases in the development of ischemic stroke in the patients with or without diabetes mellitus type II

T. Tsarenko, N. Raksha, O. Kravchenko
ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv; ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv; ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv

Abstract


Matrix metalloproteinases (MMP) are a family of zinc-dependent endopeptidases, capable of degrading all the molecular components of extracellular matrix. A class of metalloproteinases–gelatinases, which includes gelatinase A or MMP-2 (72 kDa) and gelatinase B or MMP-9 (92 kDa) has been shown to play critical roles in a number of acute and chronic pathological processes, in particular, cardiovascular diseases. For these reasons gelatinasesobtained a great interest as potential non-invasive biomarkers in providing useful clinical information in stroke diagnosis and therapy. In present study we have analyzed the content of MMP-9 and MMP-2 in serum samples of patients with ischemic stroke alone and ischemic stroke complicated by diabetes mellitus type II, as well as the enzymatic activities presented in blood serum. It has been established that the acute phase of ischemic stroke is accompanied by the significant change of the content of investigated metalloproteinases in the blood serum. The obtained results demonstrated thatblood serum content of MMP-2 is significantly higher than content of MMP-9.The changes of the content of MMP-2 and MMP-9 were more pronounced in the group of patients with ischemic stroke and diabetes mellitus type 2 comparing with the results of patients with ischemic stroke alone.For analysis of forms of gelatinases the gelatine zymographytechnique was applied. This is a sensitive and simplemethodwhich allows to measure the relative amounts of active and inactive enzymes in body fluids and tissue extracts. The serum samples patients with stroke alone and complicated by diabetescontained two prominent gelatinolyticbands corresponding to monomeric proMMP-9 (92 kDa), proMMP-2 (72 kDa)active MMP-9 (85 kDa), MMP-2 (67 kDa)and some additional bands migrating above 100 kDa. By contrast, the healthy serum samplesdisplayed only the 92 and 72 kDa proforms.


Keywords


ischemic stroke, diabetes mellitus type II, matrix metalloproteinases

Full Text:

PDF>PDF

References


Pandey A. Type

Castillo J., Rodríguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice // Cerebrovasc Dis. – 2004. – 1. – P. 7–18.

Derosa G., Ferrari I., D'Angelo A., Tinelli C., Salvadeo S.A., Ciccarelli L., Piccinni M.N., Gravina A., Ramondetti F., Maffioli P., Cicero A.F. Matrix metalloproteinase-2 and -9 levels in obese patients // Endothelium. – 2008. – 15(4). – P. 219–224.

Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview // Front Biosci. – 2006. – 11. – P. 1696–1701.

Caird J., Napoli C., Taggart C., Farrell M., Bouchier-Hayes D.Matrix metalloproteinases 2 and 9 in human atherosclerotic and nonatherosclerotic cerebral aneurysms / Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms // Eur J Neurol. 200613(10):1098-1105.

Crowther J. ELISA. Theory and practice / New Yourk. : Humana Press., 1995. – P. 38–39.

Bradford M. A rаpid and sensitive method for quantities of utilizing the principle of protein binding // Analytical Biochemistry. – 1976. – V. 86. – P. 193–200.

Ostapchenko L., Savchuk O., Burlova-Vasilieva N. Enzyme electrophoresis method in analysis of active componenets of hemostasis system // Advances in Bioscience and Biotechnology. – 2011. – 2(1). – P. 20–26.

Egashira Y., Zhao H., Hua Y., Keep R.F., Xi G. White Matter Injury After Subarachnoid Hemorrhage: Role of Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 // Stroke. – 2015. – 46(10). – P. 2909–2915.

Romanic A., White R., Arleth A., Ohlstein E., Barone F. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size // Stroke. – 1998. – 5. – P. 1020–1030.

Siwik D., Colucci W. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium // Heart Fail Rev. – 2004. – 9(1). – P. 43–51.

Zhao B., Ikeda Y., Ihara H., Urano T., Fan W., Mikawa S., Suzuki Y., Kondo K., Sato K., Nagai N., Umemura K. Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice // Blood. – 2004. – 103. – P. 2610–2616.

Rosell A., Cuadrado E., Ortega-Aznar A Mmp-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type iv collagen degradation during hemorrhagic transformation after human ischemic stroke // Stroke. – 2008. – 39. – P. 1121–1126.

Lee S., Kim H., Rogowska J., Zhao B., Bhide P., Parent J., Lo E. Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke // J Neurosci. – 2006. – 26. – P. 3491–3495.

Bouloumié A., Sengenès C., Portolan G., Galitzky J., Lafontan M.Adipocyte Produces Matrix Metalloproteinases 2 and 9 Involvement in Adipose Differentiation // Diabetes. – 2001. – 50(9). – P. 2080–2086.

Bourlier V., Zakaroff-Girard A., De Barros S., Pizzacalla C., de Saint Front V.D., Lafontan M., Bouloumié A., Galitzky J. Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation // J Pharmacol Exp Ther. – 2005. – 312(3). – Р. 1272–1279.

Rajagopalan S., Meng X., Ramasamy S., Harrison D., Galis Z. Reactive oxygen species produced by macrophagederived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability // J. Clin. Invest. – 1996. – 98. – P. 2572–2579.

Park A., Matrisian L., Kells A., Pearson R., Yuan Z., Navre M. Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch" // J Biol Chem. – 1991. – 266(3). – P. 1584–1590.

Wang X., Lee S., Arai K., Lee S., Tsuji K., Rebeck G., Lo E. Lipoprotein receptormediated induction of matrix metalloproteinase by tissue plasminogen activator // Nat Med. – 2003. – 9. – P. 1313–1317.

***

Received: 03.04.2018

Revised: 11.05.2018

Signed for publication: 11.05.2018




DOI: http://dx.doi.org/10.17721/1728_2748.2018.75.63-69

Refbacks

  • There are currently no refbacks.


Лицензия Creative Commons
This journal is available according to the Creative Commons License «Attribution» («Атрибуція») 4.0 Global (CC-BY).